what is a glp-1 agonist Non-insulin injectable antidiabetic drugs - agonists and amylinomimetics GLP-1 receptor agonists show promise
Description
Molecular Mechanisms behind Obesity and Their Potential Exploitation in Current and Future Therapy

Adv Drug Delivery Rev

Diabetes Obes Metab 2017;19:953961 [DOI] [PMC free article] [PubMed] [Google Scholar] 56.Federici MO, McQuillan J, Biricolti G, et al

asahq.org
But they deserve discussion because some offer genuine, if modest, benefits, and many people want non-pharmaceutical options as a starting point or complement
Meanwhile, ZEPBOUND generated USD 1.91 billion in U.S